WINDSOR ANAHEIM HEALTHCARE LTD

Windsor Anaheim Healthcare Ltd. operates as a provider of skilled healthcare services within the long-term care and residential support sector, as indicated by its primary NAICS code 623110. The firm delivers direct patient care, nursing support, and daily living assistance to vulnerable populations in institutional settings, with a focus on operational compliance, care coordination, and regulatory adherence in post-acute environments. Technical expertise includes clinical documentation, medication management, infection control protocols, and staff training aligned with CMS and state health department standards. While no certifications are listed, the company’s operational model suggests deep familiarity with Medicaid/Medicare reimbursement frameworks, OBRA regulations, and quality assurance benchmarks for skilled nursing facilities. No award history is available to identify specific federal agencies or contracting relationships, and no recent contracts have been recorded to infer agency-specific engagement patterns. Consequently, there is no verifiable data to confirm direct federal contracting activity or interagency collaboration. The company’s industry focus is centered on long-term care services under NAICS 623110, which encompasses nursing care facilities providing 24-hour residential care for individuals requiring ongoing medical supervision. This vertical specialization positions the firm within the broader aging and disability support market, serving populations with chronic conditions, mobility impairments, and cognitive decline. The business operates with a service delivery model grounded in person-centered care, clinical oversight, and regulatory compliance rather than technology integration or systems procurement. Windsor Anaheim Healthcare Ltd. is structured as a small business entity under the 2K classification, indicating limited scale and likely local market orientation. It is headquartered in Anaheim, California, with no public certifications on record. Its government market presence, if any, remains undetermined due to the absence of federal contract data. The company’s positioning appears rooted in state-regulated healthcare delivery rather than federal procurement channels.